Small Molecule Drug Discovery Market Report 2026

Small Molecule Drug Discovery Market Overview

• Small Molecule Drug Discovery market size has reached to $67.94 billion in 2025 • Expected to grow to $117.05 billion in 2030 at a compound annual growth rate (CAGR) of 11.6% • Growth Driver: Chronic Disease Surge Propels Growth In Small Molecule Drug Discovery Market • Market Trend: Strategic Partnerships Fueling Revenue Growth In Small Molecule Drug Discovery Market • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Small Molecule Drug Discovery Market?

Small Molecule Drug Discovery refers to the process of identifying and developing low molecular weight compounds that can interact with specific biological targets to treat diseases. It is used to create effective medications that can modulate biological pathways, ultimately leading to improved therapeutic outcomes. The main small molecule drug discovery drug types are small molecule drugs, and biologic drugs. A small-molecule drug refers to any organic chemical with a relatively low molecular weight, less than 900 daltons, that influences a biological process. the various technologies are high throughput screening, pharmacogenomics, combinatorial chemistry, nanotechnology, and others used in various therapeutic areas that are oncology, central nervous system, cardiovascular, respiratory, metabolic disorders, gastrointestinal, others. The process or phases are target id or validation, hit generation and selection, lead identification, lead optimization used by pharmaceutical companies, contract research organizations, and others.

What Is The Small Molecule Drug Discovery Market Growth Forecast?

The small molecule drug discovery market size is expected to see rapid growth in the next few years. It will grow to $117.05 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to integration of ai and machine learning in drug discovery, expansion of precision medicine initiatives, increasing collaborations between biotech and pharma, adoption of automated high-throughput platforms, growing focus on rare and complex diseases. Major trends in the forecast period include high-throughput screening adoption, combinatorial chemistry advancements, nanotechnology integration in drug design, personalized medicine development, target validation and lead optimization enhancements.

Global Small Molecule Drug Discovery Market Segmentation

1) By Drug Type: Small Molecule Drugs, Biologic Drugs 2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others 3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others 4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization 5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others Subsegments: 1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs 2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

What Is The Driver Of The Small Molecule Drug Discovery Market?

The rising incidence of chronic diseases is expected to boost the growth of the small molecule drug discovery market going forward. Chronic diseases refer to conditions that last for a year or longer, hinder everyday activities, demand continuous medical care, or both. Small-molecule medications can be used to treat chronic conditions like HIV, cancer, infections, heart disease, and renal disease, and these medications are generally more economical for patients with chronic conditions. Hence, the rising incidence of chronic diseases is expected to boost the small molecule drug discovery market. For instance, according to a 2023 report published by the National Institutes of Health (NIH), a US-based biomedical research agency, the number of people aged 50 and older with at least one chronic illness in the United States is expected to reach 142.66 million by 2050. Additionally, the population experiencing multimorbidity is projected to grow to 14.968 million by 2050. Therefore, the rising incidence of chronic diseases is driving the growth of the small molecule drug discovery industry.

Key Players In The Global Small Molecule Drug Discovery Market

Major companies operating in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Allarity Therapeutics, Cyteir Therapeutics, BigHat Biosciences

Global Small Molecule Drug Discovery Market Trends and Insights

Major companies operating in small molecule drug discovery are undergoing partnerships to drive revenues in the market. Partnerships often foster innovation by combining the expertise of different entities. For instance, in November 2023, Evommune, a US-based non-profit organization, and Accutar Biotechnology, a US-based biotechnology company, announced a strategic partnership focused on AI-based drug discovery, specifically targeting chronic inflammatory diseases. This collaboration aims to leverage Accutar's proprietary AI platform and Evommune's expertise to discover novel small molecule drug candidates.

What Are Latest Mergers And Acquisitions In The Small Molecule Drug Discovery Market?

In April 2025, Johnson & Johnson, a US-based biopharmaceutical company providing prescription pharmaceuticals, medical devices, and consumer health products, acquired Intra Cellular Therapies, Inc. for an undisclosed amount. With this acquisition, Johnson & Johnson aims to strengthen its neuroscience portfolio, expand its small-molecule central nervous system therapeutic capabilities, and accelerate growth in mental health and neurodegenerative disease treatments. Intra Cellular Therapies, Inc. is a US-based biopharmaceutical company developing small-molecule central nervous system drugs, including therapies for psychiatric and neurodegenerative disorders.

Regional Insights

North America was the largest region in the small molecule drug discovery market in 2025. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Small Molecule Drug Discovery Market?

The small molecule drug discovery market consists of sales of diphenhydramine, aspirin, and other “medicine cabinet” drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Small Molecule Drug Discovery Market Report 2026?

The small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule drug discovery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.